OB/GYN Clinical Alert – October 1, 2015
October 1, 2015
View Issues
-
Flibanserin: A Billion Dollar Market?
On the third attempt, the FDA approved the treatment for generalized hypoactive sexual desire disorder in premenopausal women.
-
Quality of Information on Pelvic Organ Prolapse on the Internet
After review of more than 400 websites, most web-based information available to women regarding pelvic organ prolapse treatment is incomplete. The best-quality information was found on government-sponsored websites.
-
Can Cerebroplacental Ratio Predict Neonatal Mortality?
Recent articles show the cerebroplacental ratio to be a useful predictor of immediate and later neonatal morbidity, particularly, in late-onset intrauterine growth restriction.
-
Morcellation: Has it Improved Outcomes or Put Women at Risk?
Widespread concern over malignant tumor dissemination with morcellation threatens to undermine advances in minimally invasive gynecologic surgery that have benefited women. Before providers abandon this technique, they should put the risks and benefits in perspective.